OTC · Medical - Pharmaceuticals

Canopus Biopharma, Inc. (CBIA) Stock

$0.00 OTC: CBIA Healthcare

Canopus Biopharma, Inc. engages in the acquisition of businesses.

Valuation

MetricValue
Price$0.00
Market Cap$455071
P/E Ratio-0.01
P/B Ratio-0.83
P/S Ratio0.00
EPS (TTM)$-0.01
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.77
Current Ratio0.24

Annual Financials (USD)

Metric2012201320212022
Revenue$0$0$0$0
Operating Profit$0$-1.0M$0$-1.0M
Net Profit$-1.0M$-1.0M$0$-1.0M
EPS$-0.02$-0.02$0.00$-0.01
Op Margin————

Balance Sheet (USD)

Metric2012201320212022
Total Assets$2.0M$2.0M$0$0
Total Liabilities$4.0M$2.0M$0$0
Cash$0$0$0$0
Borrowings$4.0M$2.0M$0$0

Cash Flow (USD)

Metric2012201320212022
Operating Cash Flow$-1.0M$2.0M$0$0
Investing Cash Flow$0$-2.0M$0$0
Financing Cash Flow$0$0$0$0
Net Cash Flow$0$0$0$0
Free Cash Flow$-1.0M$2.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.60
FCF Yield-1.36%
Quick Ratio0.24
Interest Coverage-5272.83
Return 1Y900.00%
Return 3Y-95.83%
Return 5Y-99.88%

Ownership

Insiders Held65.52%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Hollencrest Capital Management80,0002022-09-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AGINAmerican Graphite Technologies, Inc. $0.00 — 9.50 $182558 0.00%
APHDApogee 21 Holdings, Inc. $1.70 +0.00% -15.90 $722510 0.00%
CCWFChurch & Crawford, Inc. $0.00 — — $2.25M 0.00%
CHIFChina Food and Beverage Company $0.00 — 0.00 $2326 0.00%
FBDSFuss Brands Corp $0.10 +0.00% -16.83 $2.17M 0.00%

About Canopus Biopharma, Inc.

Canopus Biopharma, Inc. engages in the acquisition of businesses. The company was founded on April 8, 1986 and is headquartered in Las Vegas, NV.

Canopus Biopharma, Inc. (CBIA) stock trades at $0.00 with a market capitalization of $455071. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of -0.83, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Canopus Biopharma, Inc. generates an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.blueheaven.cafe

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides